Stephen Spagnol, PhD

Director, Enabling Technologies at Merck

Speaker

Stephen Spagnol is Director of Business Development & Licensing, Enabling Technologies at Merck, where he leads search and evaluation initiatives across Drug Delivery & Formulation, Vaccine Discovery & Adjuvant Platforms, Vaccine & Biologics Bioprocess Platforms as well as Genetic Medicine Platforms spanning Cell & Gene Therapy, mRNA/RNA Modalities and Gene Editing.

Prior to Business Development & Licensing, Stephen held roles in Research & Development spanning novel and new‑modality therapeutics, including mRNA vaccines, RNA therapeutics, and viral vector platforms for Cell &Gene Therapy. His experience spans Discovery and Development leading the development of novel mRNA/RNA delivery technologies, viral vector platforms, and formulation and process development for late-stage (Phase 3) clinical development and BLA-enabling activities.

Stephen received a Ph.D. in Chemical Engineering from Carnegie Mellon University and a B.S. in Chemical Engineering from The Pennsylvania State University.